XP-102

· Xynomic Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP-102, covering 2025-04-10 to 2025-04-10. Get the full timeline:

Most recent: Clinical Trial Update: XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation [Phase 1, Phase 2]

See pricing